A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of SYR-322 When Used in Combination With Thiazolidine in Subjects With Type 2 Diabetes in Japan

Name: A Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study to Determine the Efficacy and Safety of SYR-322 When Used in Combination With Thiazolidine in Subjects With Type 2 Diabetes in Japan
Creator: Vivli
Published: 2025-01-06 16:17:05
License: 暂无描述

DataCite Commons2025-01-06 更新2026-05-07 收录

下载链接：

https://search.vivli.org/doiLanding/studies/00002532/isLanding

下载链接

链接失效反馈

官方服务：

资源简介：

The purpose of this study was to evaluate the efficacy and safety of alogliptin, once daily (QD) combined with a thiazolidine taken QD in type 2 diabetic patients with uncontrolled blood glucose.

提供机构：

Vivli

创建时间：

2018-10-27